Evidence map›Paper›PMID 34957518›Full record

ArticleInteractive cardiovascular and thoracic surgery2022

Long-term follow-up of thoracoscopic ablation in long-standing persistent atrial fibrillation.

Niels Harlaar, Maurice A Oudeman, Serge A Trines, Gijsbert S de Ruiter, Bart J Mertens, Muchtair Khan, Robert J M Klautz, Katja Zeppenfeld, Andrew Tjon, Jerry Braun and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Interactive cardiovascular and thoracic surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Niels HarlaarDepartment of Cardiothoracic Surgery, Leiden University Medical Center, Leiden, Netherlands.ORCID 0000-0003-2790-8708
Maurice A OudemanDepartment of Cardiothoracic Surgery, OLVG, Amsterdam, Netherlands.
Serge A TrinesDepartment of Cardiology, Leiden University Medical Center, Leiden, Netherlands.
Gijsbert S de RuiterDepartment of Cardiology, OLVG, Amsterdam, Netherlands.
Bart J MertensDepartment of Biomedical Data Sciences, Leiden University Medical Center, Leiden, Netherlands.
Muchtair KhanDepartment of Cardiology, OLVG, Amsterdam, Netherlands.
Robert J M KlautzDepartment of Cardiothoracic Surgery, Leiden University Medical Center, Leiden, Netherlands.
Katja ZeppenfeldDepartment of Cardiology, Leiden University Medical Center, Leiden, Netherlands.ORCID 0000-0001-6645-082X
Andrew TjonDepartment of Cardiothoracic Surgery, OLVG, Amsterdam, Netherlands.
Jerry BraunDepartment of Cardiothoracic Surgery, Leiden University Medical Center, Leiden, Netherlands.ORCID 0000-0002-4504-6235
Thomas J van BrakelDepartment of Cardiothoracic Surgery, Leiden University Medical Center, Leiden, Netherlands.
Leiden University Medical Center · NLOLVG · NL

Funding

Department of Cardiothoracic SurgeryMedtronicThe Department of Cardiothoracic Surgery
6 · The paper itself

Abstract

objectivesCatheter ablation of long-standing persistent atrial fibrillation (LSPAF) remains challenging, with suboptimal success rates obtained following multiple procedures. Thoracoscopic ablation has shown effective at creating transmural lesions around the pulmonary veins and box; however, long-term rhythm follow-up data are lacking. This study aims, for the first time, to assess the long-term outcomes of thoracoscopic pulmonary vein and box ablation in LSPAF.

methodsRhythm follow-up consisted of continuous rhythm monitoring using implanted loop recorders or 24-h Holter recordings. Rhythm status and touch-up interventions were assessed up to 5 years.

resultsSeventy-seven patients with symptomatic LSPAF underwent thoracoscopic ablation in 2 centres. Freedom from atrial arrhythmias at 5 years was 50% following a single thoracoscopic procedure and 68% allowing endocardial touch-up procedures (performed in 21% of patients). The mean atrial fibrillation burden in patients with continuous monitoring was reduced from 100% preoperatively to 0.1% at the end of the blanking period and 8.0% during the second year. Antiarrhythmic drug use decreased from 49.4% preoperative to 12.1% and 14.3% at 2 and 5 years, respectively (P < 0.001). Continuous rhythm monitoring resulted in higher recurrence detection rates compared to 24-h Holter monitoring at 2-year follow-up (hazard ratio: 6.5, P = 0.003), with comparable recurrence rates at 5-year follow-up.

conclusionsThoracoscopic pulmonary vein and box isolation are effective in long-term restoration of sinus rhythm in LSPAF, especially when complemented by endocardial touch-up procedures, as demonstrated by the 68% freedom rate at 5 years. Continuous rhythm monitoring revealed earlier, but not more numerous documentation of recurrences at 5-year follow-up.

Indexed as

Atrial FibrillationCatheter AblationPulmonary VeinsFollow-Up StudiesHumansRecurrenceThoracoscopyTreatment OutcomeAblationAtrial fibrillationLong-standing persistentSurgeryThoracoscopy

Identifiers

PMID34957518
PMCPMC9159446
OpenAlexW4200428401

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.